The ALS Canada Board of Directors is pleased to announce the appointment of Tammy Moore as Chief Executive Officer to ALS Canada, effective November 10, 2014

MARKHAM, November 10, 2014 – The ALS Canada Board of Directors is pleased to announce the appointment of Tammy Moore as Chief Executive Officer to ALS Canada, effective November 10, 2014.

Earlier this year, ALS Canada underwent a leadership transition, requiring the ALS Canada Board of Directors to embark on a competitive and comprehensive recruitment process to fill the role of CEO. Upon completing a thorough and rigorous process, Ms. Moore was chosen to execute ALS Canada’s strategic vision.

Ms. Moore has been involved with ALS for six years and ALS Canada for over a year as a Board Member. She left the Board to fulfill the Interim CEO role this past May. During the seven month transition, she has proven herself to be a strong and capable leader, engaging staff, the ALS community, government and the public through a period of unprecedented change and growth, following the merger with ALS Ontario and during the ALS Ice Bucket Challenge.

“Ms. Moore brings the skills, abilities and passion to fulfill this leadership role,” says Lanny McInnes Chair of ALS Canada Board.  “Personally connected to the cause, she has an innate understanding of the ALS Community and an unwavering dedication to help change the future of ALS.”

Prior to this role, Ms. Moore has over two decades of experience as both an entrepreneur and communications expert, founding and building a successful branding and integrated advertising agency. She has worked with organizations in consulting positions contributing at C- Suite level management and on special projects.  She has been actively involved in non-profit organizations as a Board Member and Chair of the Women’s Enterprise Centre of BC, a founding Member of BC Cancer Foundation – Southern Interior Advisory Council, Board Executive for the Kelowna Art Gallery and President of the Rotary Club of Kelowna – Ogopogo.

ALS Canada’s Board of Directors and Staff congratulate Ms. Moore as the organization’s new CEO. Her leadership and experience will be a catalyst to enable ALS Canada to continue as the leading organization to support people in Ontario living with ALS, and in fulfilling its vision to make ALS a treatable, not terminal disease.

About ALS

ALS, amyotrophic lateral sclerosis is a neurodegenerative disease where the cells in the body that control movement die. The “living wires” which connect a person’s brain to their muscles degenerate, leading to a loss of mobility and eventual paralysis, changes or complete loss of speech and eventually the ability to breathe. ALS is a terminal disease that has no cure, and no effective treatment. Approx. 2,500-3,000 Canadians are living with ALS.  It is estimated 1,000 Canadians will die annually of ALS and 1,000 will be newly diagnosed each year. The average lifespan is two to five years.

About ALS Canada

The ALS Society of Canada was founded in 1977 and is the only national registered charity dedicated to ALS. ALS Canada is responsible for the ALS Canada Research Program – funding peer reviewed research grants and fostering collaboration amongst Canadian researchers, helping to nurture new ideas and build capacity. ALS Canada has a role in Ontario, similar to that of the Provincial ALS Societies, providing services and support for people living with ALS within our provinces. ALS Canada advocates federally in partnership with the Provincial Societies on behalf of people and their families for better government support and access to federal research funding programs. Follow ALS Canada @ALSCanada and for more information visit